With its Largest SEMA Show Presence to Date, Toyota Promises Adventure On or Off the Beaten Path LAS VEGAS, Oct. 31, 2023 /PRNewswire/ -- Toyota returns to the Specialty Equipment Market...

BerGenBio ASA (OSE: BGBIO), a clinical-stage biopharmaceutical company developing novel, selective AXL kinase inhibitors for severe unmet medical needs, today announced that a poster highlighting...

- Data demonstrate feasibility, tolerability, and early efficacy of mRNA/LNP in vivo CAR-M therapy in pre-clinical models of metastatic solid tumors - Proof of concept achieved for platform under...

Nilfisk, one of the world's leading manufacturers of professional cleaning equipment, is excited to return to ISSA after three years to showcase its high-performance products—including the...

Poster presentation describes the development of SNAP CAR platform technology as a "universal" CAR therapy with the potential to target multiple antigens through combinatorial use of different...

Qualtrics, the leader and creator of the experience management category, today announced X4: The Experience Management Summit is returning to Salt Lake City May 1-3, 2024. Registration is open...

Ampio Pharmaceuticals, Inc. (NYSE American: AMPE) (the "Company), a pre-revenue stage biopharmaceutical company focused on development of a potential treatment for osteoarthritis as part of its...

Poster presentation describes potential of oncology programs RBI-1000 and RBI-3000 to target known acquired resistance mutations SAN DIEGO, Oct. 31, 2023 /PRNewswire/ -- Replicate Bioscience, a...

COM503, a potential first-in-class, high affinity anti-IL18 binding protein antibody frees endogenous IL-18 to inhibit cancer growth Anti-IL-18BP antibody immune modulation is confined to the...

In vitro proof-of-concept for novel myeloid and B cell modulating anti-CLEC2D-TLR9 agonist conjugate program, a compelling immunotherapeutic approach to induce T and NK cell recruitment in tumors...

Carrier Global Corporation (NYSE: CARR) Chairman & CEO David Gitlin will speak at the Baird 2023 Global Industrial Conference on Tuesday, Nov. 7, 2023 at 12:25 p.m. ET. The event will be broadcast...

Flare Therapeutics Inc., a clinical-stage biotechnology company targeting transcription factors to discover precision medicines for cancer and other diseases, today announced a poster presentation...

Deloitte, KPMG, and PwC offer the Workday Industry Accelerator for Insurance to Speed Time to Value for Insurance Industry Customers LAS VEGAS, Oct. 31, 2023 /PRNewswire/ -- InsureTech Connect...

Perrigo Company plc (NYSE: PRGO), a leading provider of Consumer Self-Care Products, today announced that President and CEO, Patrick Lockwood-Taylor and CFO Eduardo Bezerra are scheduled to...

Ultraviolette's futuristic pavilion – the UV Space Station at 2023 EICMA will feature a cutting-edge product and technology showcase at Hall 22P, Stand Q20 International Press conference on...

Company to present on its ongoing Phase 1 ovarian cancer CAR-T trial SAN JOSE, Calif., Oct. 31, 2023 /PRNewswire/ -- Anixa Biosciences, Inc. ("Anixa" or the "Company") (NASDAQ: ANIX), a...

Following a decade of cord-cutting, that has seen pay-TV subscribers churning to paid online video services, Omdia expects 2024 to bring a new stage of market evolution, with users of paid online...

ERI Offers Dynamic Topics Presented by Leading Experts for School-Based Physical Therapists, Occupational Therapists, Speech-Language Pathologists and Special Educators. BOSTON, Oct. 31, 2023...

QuickLogic Corporation (NASDAQ: QUIK), a developer of embedded FPGA (eFPGA) IP, ruggedized FPGAs, and Endpoint AI/ML solutions, will present at the Radiation Hardened Electronic Technologies...

Company-wide research offers novel pathways for enhancing kidney patient care using data-driven insights and real-world evidence WALTHAM, Mass., Oct. 31, 2023 /PRNewswire/ -- Fresenius Medical...

Company's accepted scientific abstracts and corporate workshop to highlight the utility of HDPCR™ technology and the ChromaCode Cloud software in enabling best-in-class multiplexing and sample...

HDT Bio Corp., a clinical-stage private company developing advanced RNA products to treat and prevent infectious diseases and cancer, today announced that Dr. Steven Reed, Chief Executive Officer...

Accuray Incorporated (NASDAQ: ARAY) announced today its participation in the 14th Annual Jefferies London Healthcare Conference. The management team is scheduled to participate in a presentation...

Clario, a healthcare research technology company that delivers the leading endpoint technology solutions for clinical trials, announces a three-part educational webinar series on oncology trial...

ICP DAS – Biomedical Polymers, Asia's first medical-grade TPU (thermoplastic polyurethane) manufacturer and supplier, will be exhibiting at COMPAMED in Germany and IPF in Japan in November and...